Treatment of metastatic urothelial cancer in the post-MVAC era

Authors
Cohen, EEW Stadler, WM
Citation
Eew. Cohen et Wm. Stadler, Treatment of metastatic urothelial cancer in the post-MVAC era, WORLD J URO, 19(2), 2001, pp. 126-132
Citations number
62
Categorie Soggetti
Urology & Nephrology
Journal title
WORLD JOURNAL OF UROLOGY
ISSN journal
07244983 → ACNP
Volume
19
Issue
2
Year of publication
2001
Pages
126 - 132
Database
ISI
SICI code
0724-4983(200104)19:2<126:TOMUCI>2.0.ZU;2-T
Abstract
The combination of methotrexate, vinblastine, doxorubicin, and cisplatin (M VAC) has become the standard of care for metastatic urothelial cancer. Its efficacy has been proven in this setting but it can be a difficult regimen to tolerate. With the introduction of new active agents, different combinat ions are being evaluated. This article will highlight the use of these new regimens with emphasis on those employing gemcitabine or the taxanes.